Chidamide plus venetoclax as effective and safe maintenance therapy in high-risk acute myeloid leukemia and myelodysplastic syndrome post-transplantation.

Epidaza (chidamide) - Chipscreen

Venclexta (venetoclax) - Roche, AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/42742782

Cuicui Lyu; Hairong Lyu; Haotian Meng; Mingfeng Zhao; Xia Xiao; Xianshuang Luan; Yedi Pu

Sep 16, 2026